Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1989 | 12-1988 | 12-1987 | 12-1986 | 12-1985 | |
Sales | 5,671,500 | 5,385,400 | 4,919,800 | 4,476,000 | 4,024,500 |
Cost of Goods | 2,062,300 | 2,020,100 | 1,896,900 | 1,720,400 | 1,545,700 |
Gross Profit | 3,609,200 | 3,365,300 | 3,022,900 | 2,755,600 | 2,478,800 |
Operating Expenses | 2,641,300 | 2,353,500 | 2,083,000 | 1,796,300 | 1,599,500 |
Operating Income | 968,200 | 1,011,900 | 940,800 | 959,700 | 880,000 |
Interest Expense | 126,000 | 82,500 | 63,400 | 55,500 | 78,400 |
Other Income | 74,300 | 174,400 | 133,400 | 60,700 | 79,800 |
Pre-tax Income | 916,500 | 1,103,800 | 1,010,800 | 964,900 | 881,400 |
Income Tax | 231,300 | 309,400 | 317,300 | 300,700 | 296,400 |
Net Income Continuous | 681,100 | 791,300 | 690,200 | 660,000 | 579,700 |
Net Income | $681,100 | $791,300 | $690,200 | $660,000 | $579,700 |
EPS Basic Total Ops | 0.17 | 0.20 | 0.17 | 0.17 | 0.15 |
EPS Basic Continuous Ops | 0.17 | 0.20 | 0.17 | 0.17 | 0.15 |
EPS Diluted Total Ops | 0.17 | 0.20 | 0.17 | 0.17 | 0.15 |
EPS Diluted Continuous Ops | 0.17 | 0.20 | 0.17 | 0.17 | 0.15 |
EBITDA(a) | $1,175,300 | $1,206,400 | $1,102,800 | $1,106,800 | $880,000 |